The fate of bromine after temperature-induced dehydrogenation of on-surface synthesized bisheptahelicene.

The on-surface synthesis of bisheptahelicene by Ullmann coupling of 9-bromoheptahelicene on Au(111) and its temperature-induced dehydrogenation is studied using temperature-programmed reaction spectroscopy and time-of-flight secondary ion mass spectrometry. Specific dehydrogenation products of bisheptahelicene after loss of 6, 8 and 10 hydrogen atoms are identified, corresponding to molecules having undergone Diels-Alder transformations and intramolecular C-C coupling reactions. By combining with atomic hydrogen produced by dehydrogenation, the Ullmann coupling side-product bromine desorbs as HBr. H2 desorption emerges only after all Br has desorbed. Such characteristic behavior is explained by a kinetic model which explicitly considers the coverage of transient atomic H on the surface. Heating experiments performed with saturated layers of different Br-containing molecules reveal that the onset of HBr desorption depends strictly on the dehydrogenation step and therefore on the structure of the molecules.

Diastereoselective Ullmann Coupling to Bishelicenes by Surface Topochemistry.

The comparison of the self-assembly 9,9'-bisheptahelicene on the Au(111) surface, studied with scanning tunneling microscopy, with the self-assembly of the same species obtained by on-surface synthesis via Ullmann coupling from 9-bromoheptahelicene reveals a diastereomeric excess for the ( M, P)- meso-form of 50%. The stereoselectivity is explained by a topochemical effect, in which the surface-alignment of the starting material and the organometallic intermediate sterically favor the ( M, P)-transition state over the homochiral transition states.

Diastereoselective self-assembly of bisheptahelicene on Cu(111).

Stereochemical effects during two-dimensional crystallization of bisheptahelicene diastereomers on a Cu(111) surface have been studied with scanning tunnelling microscopy. The (M,M)- and (P,P)-enantiomers crystallize into a monolayer racemate lattice, whereas the (M,P)-diastereomers aggregate into their own monolayer phase.

Stereospecific Autocatalytic Surface Explosion Chemistry of Polycyclic Aromatic Hydrocarbons.

Autocatalytic processes are important in many fields of science, including surface chemistry. A better understanding of its mechanisms may improve the current knowledge on heterogeneous catalysis. The thermally induced decomposition of eight different polycyclic aromatic hydrocarbons (PAHs) on a saturated monolayer of atomic oxygen on a Cu(100) surface is studied using temperature-programmed reaction spectroscopy (TPRS), X-ray photoelectron spectroscopy (XPS), and scanning tunneling microscopy (STM). 9-Bromo-heptahelicene decomposes autocatalytically in a narrow temperature range into CO2 and H2O, while non-halogenated heptahelicene decomposes into the same products but does not show autocatalytic behavior. Fixation of the hydrocarbon to the surface via the organometallic bond after elimination of the bromine is identified as a prerequisite for the autocatalytic reaction mechanism. Of all the hydrocarbons studied, only those being sterically overcrowded decompose autocatalytically. Such an observation can be explained by facile dehydrogenation of the overcrowded PAHs. The reaction of such hydrogen with oxygen creates vacancies in the oxygen layer which act as active sites and catalyze further decomposition.

A nanomolar multivalent ligand as entry inhibitor of the hemagglutinin of avian influenza.

Influenza virus attaches itself to sialic acids on the surface of epithelial cells of the upper respiratory tract of the host using its own protein hemagglutinin. Species specificity of influenza virus is determined by the linkages of the sialic acids. Birds and humans have α2-3 and α2-6 linked sialic acids, respectively. Viral hemagglutinin is a homotrimeric receptor, and thus, tri- or oligovalent ligands should have a high binding affinity. We describe the in silico design, chemical synthesis and binding analysis of a trivalent glycopeptide mimetic. This compound binds to hemagglutinin H5 of avian influenza with a dissociation constant of K(D) = 446 nM and an inhibitory constant of K(I) = 15 µM. In silico modeling shows that the ligand should also bind to hemagglutinin H7 of the virus that causes the current influenza outbreak in China. The trivalent glycopeptide mimetic and analogues have the potential to block many different influenza viruses.

Donor assists acceptor binding and catalysis of human α1,6-fucosyltransferase.

α1,6-Core-fucosyltransferase (FUT8) is a vital enzyme in mammalian physiological and pathophysiological processes such as tumorigenesis and progress of, among others, non-small cell lung cancer and colon carcinoma. It was also shown that therapeutic antibodies have a dramatically higher efficacy if the α1,6-fucosyl residue is absent. However, specific and potent inhibitors for FUT8 and related enzymes are lacking. Hence, it is crucial to elucidate the structural basis of acceptor binding and the catalytic mechanism. We present here the first structural model of FUT8 in complex with its acceptor and donor molecules. An unusually large acceptor, i.e., a hexasaccharide from the core of N-glycans, is required as minimal structure. Acceptor substrate binding of FUT8 is being dissected experimentally by STD NMR and SPR and theoretically by molecular dynamics simulations. The acceptor binding site forms an unusually large and shallow binding site. Binding of the acceptor to the enzyme is much faster and stronger if the donor is present. This is due to strong hydrogen bonding between O6 of the proximal N-acetylglucosamine and an oxygen atom of the ß-phosphate of GDP-fucose. Therefore, we propose an ordered Bi Bi mechanism for FUT8 where the donor molecule binds first. No specific amino acid is present that could act as base during catalysis. Our results indicate a donor-assisted mechanism, where an oxygen of the ß-phosphate deprotonates the acceptor. Knowledge of the mechanism of FUT8 is now being used for rational design of targeted inhibitors to address metastasis and prognosis of carcinomas.